Total adiponectin in overweight and obese subjects and its response to visceral fat loss
Tóm tắt
Từ khóa
Tài liệu tham khảo
Obesity: preventing and managing the global epidemic. Report of a WHO consultation, World Health Organ Tech Rep Ser 894 (2000), pp. I–xii 1–253.
The Report of a British Nutrition Foundation Task Force. Cardiovascular disease, Diet, Nutrition and Emerging Risk Factors. Oxford: Balckwell Publishing Ltd; 2005.
Malik A, Babir A, Abi Saab B, Roglic G, King H. Glucose intolerance and associated factors in the UAE. Diabetes Res Clin Pract. 2005;69:188–95.
Gariballa S, Kosanovic M, Yasin J, Essa AE. Oxidative damage and inflammation in obese diabetic emirati subjects. Nutrients. 2014;6(11):4872–80.
Gariballa S, Alkaabi J, Yasin J, Al Essa A. Oxidative damage and associated inflammatory risk factors in obese Emirati women. Body mass index versus waist circumference. Saudi Med J. 2017;38(9):960–4.
Expert Consultation WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.
Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.
Woodward L, Akoumianakis I, Antoniades C. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease. Br J Pharmacol. 2017;174(22):4007–20.
Sulistyoningrum DC, Gasevic D, Lear SA, Ho J, Mente A, Devlin AM. Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc Diabetol. 2013;12:170.
Lopez-Jaramillo P. The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions. J Nutr. 2016;146(2):422S–6S.
Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, Hoddy KK, Calvo Y. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutr J. 2013;12:146.
Hosseinzadeh-Attar MJ, Golpaie A, Janani L, Derakhshanian H. Effect of Weight Reduction Following Bariatric Surgery on Serum Visfatin and Adiponectin Levels in Morbidly Obese Subjects. Obes Facts. 2013;6(2):193–202.
Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res. 2005;37(11):695–701.
Shah A, Hernandez A, Mathur D, Budoff MJ, Kanaya AM. Adipokines and body fat composition in South Asians: results of the Metabolic Syndrome and Atherosclerosis in South Asians Living in America (MASALA) study. Int J Obes. 2012;36(6):810–6.
Al-Badri MR, Zantout MS, Azar ST. The role of adipokines in gestational diabetes mellitus. Ther Adv Endocrinol Metab. 2015;6(3):103–8.
Liu C, Feng X, Li Q, Wang Y, Li Q, Hua M. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis. Cytokine. 2016;86:100–9.
Altinova AE, Toruner F, Bukan N, Yasar DG, Akturk M, Cakir N, Arslan M. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J. 2007;54(2):221–6.
Barter P. High density lipoprotein: a therapeutic target in type 2 diabetes. Endocrinol Metab. 2013;28:169–77.
Hawkes N. Small falls in weight can improve health provided they are long term, says NICE. BMJ. 2014;348:g3576.
National Institute for Health and Care Excellence. Managing overweight and obesity in adults—lifestyle weight management services. 2014. http://guidance.nice.org.uk/PH53